Skip to main content
Log in

Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: In vitro restoration of this immunosuppression by thymic hormones

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

The in vitro restoring effects of a thymic hormone preparation, TP-1, on defective monocyte and dendritic cell function in patients with head and neck squamous cell carcinoma (HNSCC) have been examined. TheN-formylmethionyl-leucyl-phenylalanine(fMLF)-induced polarization of monocytes isolated from the peripheral blood was significantly lower (a mean of 19%) than the polarization of monocytes isolated from healthy controls (a mean of 33%). After the in vitro addition of TP-1 this defective polarization was improved to the normal value of 33% polarized monocytes. The capability of dendritic cells prepared from the blood to form cellular clusters with allogeneic cells was impaired in 26/44 patients. In vitro addition of TP-1 again had restoring effects. The original defective dendritic cell clustering of 97 clusters/six microscopic fields (mean) was improved to a value of 121 clusters. The defects in monocyte polarization and clustering of dendritic cells could be ascribed to the presence in serum of a tumor-derived low-molecularmass factor low-M r factor; <25 kDa) sharing structural homology with p15E, the capsular protein of murine and feline leukemogenic retroviruses. The incubation of low-M r factor from the serum of HNSCC patients with healthy donor monocytes resulted in a significantly higher inhibition of fMLF-induced monocyte polarization than did incubation with control low-M r factor (a mean of 42 versus 16% inhibition). This suppressive effect of patient low-M r factor was abrogated with a mixture of two monoclonal antibodies against p15E as well as with TP-1. The observations here reported on the in vitro effects of TP-1 on depressed monocyte and dendritic cell function in HNSCC have provided one of the rationales for a TP-1 therapeutic pilot trial recently started in HNSCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aiuti F, Fiorilli M, Schirrmacher V (1975) Effect of thymus factor on human precursor T lymphocytes. Clin Exp Immunol 20: 499

    Google Scholar 

  2. Austyn JM, Weinstein DE, Steinman RM (1988) Clustering with dendritic cells precedes and is essential for T cell proliferation in a mitogenesis model. Immunology 63: 691

    Google Scholar 

  3. Balm AJM, Drexhage HA, von Blomberg-van der Flier BME, Weltevreden EF, Veldhuizen BW, Mullink H, Snow GB (1984) Mononuclear phagocyte function in head and neck cancer. The chemotactic responsiveness of blood monocytes in correlation between the histological grade of the tumor and the infiltration of these cells into the tumor area. Cancer 54: 1010

    Google Scholar 

  4. Bergesi G, Falchetti R (1977) Chemical characterization and biological activity of a new thymic extract. Folia Allergol Immunol Clin 21: 204

    Google Scholar 

  5. Bergfelt L, Bucana C, Kripke ML (1988) Alterations in Langerhans cells during growth of transplantable murine tumors. J Invest Dermatol 91: 129

    Google Scholar 

  6. Bier J, Nicklish U (1981) Investigations of unspecific immunoreactivity in patients with head and neck carcinoma. Arch Otorhinolaryngol 232: 145

    Google Scholar 

  7. Bröcker EB, Zwadlo G, Holzmann B, Macher E, Sorg C (1988) Inflammatory cell infiltrates in human melanoma at different stages of tumor progression. Int J Cancer 41: 562

    Google Scholar 

  8. Bugelski PJ, Corwin SP, North SM, Kirsch RL, Nicholson GL, Poste G (1987) Macrophage contact of spontaneous metastases at different stages of growth. Cancer Res 47: 4141

    Google Scholar 

  9. Bugelski PJ, Kirsch R, Buscarino C, Corwin SP, Poste G (1987) Recruitment of exogenous macrophages into metastases at different stages of tumor growth. Cancer Immunol Immunother 24: 93

    Google Scholar 

  10. Cameron DJ, Stromberg BV (1984) The ability of macrophages from head and neck cancer patients to kill tumor cells. Effect of prostaglandin inhibitors on cytotoxicity. Cancer 54: 2403

    Google Scholar 

  11. Catalona WJ, Sample WF, Chretien PB (1973) Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage. Cancer 31: 65

    Google Scholar 

  12. Cianciolo GJ, Snyderman R (1981) Monocyte responsiveness to chemotactic stimuli is a property of a subpopulation of cells that can respond to multiple chemoattractants. J Clin Invest 67: 60

    Google Scholar 

  13. Cianciolo GJ, Hunter J, Silva J, Haskill JS, Snyderman R (1981) Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses. J Clin Invest 68: 831

    Google Scholar 

  14. Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R (1985) Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230: 453

    Google Scholar 

  15. Dardenne M, Bach JF (1989) Thymic hormone in the treatment of cancer. Immun Cancer 2: 363

    Google Scholar 

  16. Falchetti R, Bergesi G, Eshkol A, Cafiero C, Adorini L, Caprino L (1977) Pharmacological and biological properties of a calf thymus extract (TP-1). Drugs Exp Clin Res 3: 39

    Google Scholar 

  17. Fidler IJ (1988) Macrophage therapy of cancer metastasis. Metastases, Ciba Found Symp 141: 211

    Google Scholar 

  18. Gottlieb RA, Lennarz WJ, Knowles RD, Cianciolo GJ, Dinarello CA, Lachman LB, Kleinerman ES (1989) Synthetic peptide corresponding to a conserved domain of the retroviral protein p15E blocks IL-1-mediated signal transduction. J Immunol 142: 4321

    Google Scholar 

  19. Guyere LA, Barfoot R, Denham S, Hall JG (1987) Immunity to a syngeneic sarcoma induced in rats by dendritic lymph cells exposed to the tumour either in vivo or in vitro. Br J Cancer 55: 17

    Google Scholar 

  20. Harrell RA, Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R (1986) Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal retroviruses. J Immunol 136: 3517

    Google Scholar 

  21. Harris DT, Cianciolo GJ, Snyderman R, Argov S, Koren HS (1987) Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E. J Immunol 138: 889

    Google Scholar 

  22. Helmberg A, Fassler R, Geley S, Johrer K, Kroemer G, Bock G, Kofler R (1990) Glucocorticoid-regulated gene expression in the immune system. Analysis of glucocorticoid-regulated transcripts from the mouse macrophage-like cell line P388D1. J Immunol 145: 4332

    Google Scholar 

  23. Inaba K, Steinman RM (1986) Accessory cell-T lymphocyte interactions. Antigen-dependent and antigen-independent clustering. J Exp Med 163: 247

    Google Scholar 

  24. Inaba K, Steinman RM (1987) Monoclonal antibodies to LFA-1 and to CD4 inhibit the mixed leukocyte reaction after the antigen-dependent clustering of dendritic cells and T lymphocytes. J Exp Med 165: 1403

    Google Scholar 

  25. Iwata T, Incefy GS, Cunningham-Rundles S, Smithwick E, Geller N, O'Reilly R, Good RA (1981) Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseases. Am. J. Med. 71: 385

    Google Scholar 

  26. Iwata T, Incefy GS, Cunningham-Rundles S, Dardenne M, Kapoor N, Kirkpatrick D, O'Reilly RJ (1983) Circulating thymic hormone levels in severe combined immunodeficiency. Clin Exp Immunol 53: 1

    Google Scholar 

  27. Jenkins VK, Ray P, Ellis HN, Griffiths CM, Perry RR, Olsen MH (1976) Lymphocyte response in patients with head and neck cancer. Arch Otolaryngol 102: 596

    Google Scholar 

  28. Kabel PJ, de Haan-Meulman M, Voorbij HAM, Kleingeld M, Knol EF, Drexhage HA (1989) Accessory cells with a morphology and marker pattern of dendritic cells can be obtained from elutriatorpurified blood monocyte fractions. An enhancing effect of metrizamide in this differentiation. Immunobiology 179: 395

    Google Scholar 

  29. Kleinerman ES, Lachman LB, Knowles RD, Snyderman R, Cianciolo GJ (1987) A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1. J Immunol 139: 2329

    Google Scholar 

  30. Lafrado LJ, Lewis MG, Mathes LE, Olsen RG (1987) Suppression of in vitro neutrophil function by feline leukaemia virus (FeLV) and purified FeLV-p15E. J Gen Virol 68: 507

    Google Scholar 

  31. Lichtenstein A, Zighelboim J, Dorey F, Brossman S, Fahey JL (1980) Comparison of immune derangements in patients with different malignancies. Cancer 45: 2090

    Google Scholar 

  32. Mathes LE, Olsen RG, Hebebrand LC, Hoover EA, Schaller JP (1978) Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein. Nature 274: 684

    Google Scholar 

  33. Mitani M, Cianciolo GJ, Snyderman R, Yasuda M, Good RA, Day NK (1987) Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses. Proc Natl Acad Sci USA 84: 237

    Google Scholar 

  34. Mullink H, von Blomberg-van der Flier M, Wilders MM, Drexhage HA, Alons CL (1979) A simple cytochemical method for distinguishing EAC rosettes formed by lymphocytes and monocytes. J Immunol Methods 29: 133

    Google Scholar 

  35. Nomori H, Watanabe S, Nakajima T, Shimosato Y, Kameya T (1986) Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer 57: 100

    Google Scholar 

  36. Orosz CG, Zinn NE, Olsen RG, Mathes LE (1985) Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behaviour by inducing hyporesponsiveness to lymphokines. J Immunol 134: 3396

    Google Scholar 

  37. Pertoft H, Johnsson A, Wärmegård B, Seljelid R (1980) Separation of human monocytes on density gradients of Percoll. J Immunol Methods 33: 221

    Google Scholar 

  38. Pinsky CM, Oettgen HF, Domeiri A, Old LJ, Beatti EJ, Burchenal JH (1971) Delayed type hypersensitivity reactions in patients with cancer. Proc Am Assoc Cancer Res 62: 399

    Google Scholar 

  39. Ruegg CL, Monell CR, Strand M (1989) Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II. J Virol 63: 3250

    Google Scholar 

  40. Scheeren RA, Koopman G, vd Baan S, Meyer CJLM, Pals SP (1991) Adhesion receptors involved in early clustering of blood dendritic cells and T-lymphocytes. Eur J Immunol 21: 1101

    Google Scholar 

  41. Schmidt DM, Sidhu NK, Cianciolo GJ, Snyderman R (1987) Recombinant hydrophilic region of murine retroviral p15E inhibits stimulated T-lymphocyte proliferation. Proc Natl Acad Sci USA 84: 7290

    Google Scholar 

  42. Schroder S, Schwarz W, Rehpenning W, Loning T, Bocker W (1988) Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol 89: 295

    Google Scholar 

  43. Tan IB, Drexhage HA, Scheper RJ, von Blomberg-van der Flier BME, de Haan-Meulman M, Snow GB, Balm AJM (1986) Immunosuppressive retroviral p15E-related factors in head and neck carcinomas. Arch Otolaryngol Head Neck Surg 112: 942

    Google Scholar 

  44. Tan IB, Drexhage HA, Scheper RJ, von Blomberg-van der Flier BME, de Haan-Meulman M, Snow GB, Balm AJM (1986) Defective monocyte chemotaxis in patients with head and neck cancer. Restoration after treatment. Arch Otolaryngol Head Neck Surg 112: 541

    Google Scholar 

  45. Tan IB, Drexhage HA, Mullink H, Henzen-Logmans SC, de Haan-Meulman M, Snow GB, Balm AJM (1987) Immunohistochemical detection of retroviral p15E-related material in carcinomas of the head and neck. Otolaryngol Head Neck Surg 96: 251

    Google Scholar 

  46. Tas M, Leezenberg JA, Drexhage HA (1990) Beneficial effects of the thymic hormone preparation thymostimulin in patients with defects in cell-mediated immunity and chronic purulent rhinosinusitis. A double-blind cross-over trial on improvements in monocyte polarization and clinical effects. Clin Exp Immunol 80: 304

    Google Scholar 

  47. Tas M, de Haan-Meulman M, Kabel PJ, Drexhage HA (1991) Defects in monocyte polarization and dendritic cell clustering in patients with Graves' disease. A putative role for a non-specific immunoregulatory factor related to p15E. Clin Endocrinol 34: 441

    Google Scholar 

  48. Van de Plassche-Boers EM, Tas M, de Haan-Meulman M, Kleingeld M, Drexhage HA (1988) Abnormal monocyte chemotaxis in patients with chronic purulent rhinosinusitis: an effect of retroviral p15E-related factors in serum. Clin Exp Immunol 73: 348

    Google Scholar 

  49. Walter RJ, Danielson JR (1987) Characterization of formylpeptide chemoattractant binding on neutrophils and monocytes from patients with head and neck cancer. JNCI 78: 61

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tas, M.P.R., Simons, P.J., Balm, F.J.M. et al. Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: In vitro restoration of this immunosuppression by thymic hormones. Cancer Immunol Immunother 36, 108–114 (1993). https://doi.org/10.1007/BF01754410

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01754410

Key words

Navigation